View all news

Bristol Dental School spin-out company awarded ERDF I4G funding

handling antimicrobial materials

21 January 2019

Bristol Dental School spin-out company Pertinax Pharma Ltd are delighted to announce that they have secured funding from Innovation 4 Growth (I4G). I4G is a funding scheme managed by the University of the West of England and developed using the European Regional Development Fund. It supports SMEs in the West of England to develop innovative products, technologies, processes and services.

Pertinax will use the I4G funding to support development of a new generation of aerosol sprays, which provide a resilient, tenacious, antimicrobial coating to treat wound and skin infections.

You can read the full article here:

View the post on Linkedin:

Edit this page